Previous 10 | Next 10 |
AIkido Announces Reverse Stock Split PR Newswire NEW YORK , June 3, 2022 /PRNewswire/ -- AIkido Pharma, Inc. (NASDAQ:AIKI), today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a rat...
AIkido Pharma Announces Company Commitment to Board Diversity PR Newswire NEW YORK , May 19, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the Company's commitment to complying with the NASDAQ listing requ...
AIkido Pharma Secures Interest in Databricks Inc. PR Newswire Data and AI Company and a Pioneer of the Cutting-Edge Database Architecture NEW YORK , May 12, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today a...
/DISREGARD RELEASE: AIkido Pharma Inc./ PR Newswire We are advised by AIkido Pharma Inc. that journalists and other readers should disregard the news release, AIkido Pharma Announces Strategic Investment in Social Communications Platform Provider Discord, Inc., issued ...
AIkido Reports Slinger Bag Inc.'s Filing for Nasdaq Public Listing PR Newswire Company's Flagship Product, The Slinger Bag, Top Rated Among 2022 Tennis Products NEW YORK , May 5, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or ...
AIkido Pharma Announces Strategic Investment in Social Communications Platform Provider Discord, Inc. PR Newswire Discord Reportedly Interviewing Investment Bankers About Going Public This Year NEW YORK , May 4, 2022 /PRNewswire/ -- AIkido Pharma ...
Blockchain-enabled cybersecurity, metaverse advertising platform and social media company, DatChat (NASDAQ:DATS), entered into a strategic alliance with House of Kibba. The alliance aims to integrate DATS non-fungible token, or NFT, monetization platform into the Looking Glass Labs subsi...
Glass Lewis Proxy Paper Report Recommends "FOR" AIkido Pharma Inc. Proposed Reverse Stock Split PR Newswire Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company NEW YORK , April 22, 2022 /PRNewswire/ -- AIkido Pharma Inc....
AIkido Pharma Inc. (NASDAQ:AIKI) traded at a new 52-week high today of $2.74. This new high was reached on above average trading volume as 246.1 million shares traded hands, while the average 30-day volume is approximately 1.4 million shares. AIkido Pharma Inc is a biotechnology company ...
AIkido Pharma Announces Strategic Investment in MasterClass PR Newswire Masterclass Provides Members Access to Pre-Recorded Lectures by Top Experts NEW YORK , April 5, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Compan...
News, Short Squeeze, Breakout and More Instantly...
AIkido Pharma Inc. Company Name:
AIKI Stock Symbol:
NASDAQ Market:
AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH) PR Newswire NEW YORK , Dec. 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) (the "Company") today announced that it has changed its name from AI...
AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes PR Newswire Leading Advanced Materials Company Now Listed on NASDAQ under the symbol, ASPI NEW YORK , Nov. 28, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) (...
AIkido Share Repurchase Continues PR Newswire NEW YORK , Oct. 6, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on the Company's share repurchase program (the "Share Repurchase Program") authori...